Female Condoms (Female Condom)

Subscribe to Selected New Research on Female Condoms

133 relevant articles (22 outcomes, 34 trials/studies) found for this Therapy

Description: A soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. (Med Lett Drugs Ther 1993 Dec 24;35(12):123)

Also Known As:

Female Condom; Condoms, Female; Condom, Female

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Contraceptive Devices: 79

Female Contraceptive Devices: 147

Female Condoms: 133

Experts

1.	Feldblum, P J: 3 articles (07/2007 - 08/2000)
2.	Wong, E L: 2 articles (07/2007 - 05/2001)
3.	Artz, Lynn: 2 articles (03/2005 - 01/2005)
4.	Robey, Lawrence: 2 articles (03/2005 - 01/2005)
5.	Macaluso, Maurizio: 2 articles (03/2005 - 01/2005)
6.	Austin, Harland: 2 articles (03/2005 - 01/2005)
7.	Hook, Edward W: 2 articles (03/2005 - 01/2005)
8.	Kelaghan, Joseph: 2 articles (03/2005 - 01/2005)
9.	Bwayo, J J: 2 articles (05/2001 - 08/2000)
10.	Kelaghan, J: 2 articles (05/2000 - 02/2000)

Related Diseases

1.	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/01/1999 - "Clinical trials suggest that the female condom is highly effective in preventing the transmission of HIV/STDs if used properly" 06/01/1993 - "The Food and Drug Administration approved the first so-called female condom on May 7. Despite limited data on the effectiveness of the Reality Vaginal Pouch in sexually transmitted diseases (STDs) and a relatively high pregnancy rate among users, the device was approved because it is the first barrier contraceptive for women that provides some protection against STDs" 02/01/2000 - "Results from international studies on the efficacy of female condoms include: 1) ability to prevent unwanted pregnancies; 2) ability to prevent transmission of sexually transmitted diseases and HIV; 3) expansion of choice in increasing protection; 4) acceptability of the female condom to a wide range of men and women; 4) safety of the product; 5) easier use through constant practice; 6) provision of additional emotional comfort, sense of security and control; 7) cost-effectiveness as a prevention program; and 8) the need for a more strategic introduction in other countries" 04/01/1995 - "Also recommended for use by adolescents is the new female condom--the only female-controlled method that confers protection against both pregnancy and STDs" 07/01/1993 - "Wisconsin Pharmacal Company, the US licensee of Reality, has been directed to include the message that the female condom should be used only if the male condom (claimed to be more protective against sexually transmitted diseases) cannot or will not be used" Order ALL the reference details at left...
2.	Acquired Immunodeficiency Syndrome (AIDS) 01/01/1998 - "These efforts have been bolstered by new tools, such as the female condom; new research findings that have reduced maternal-child transmission; new treatments; new hope in the form of improved care for people with HIV/AIDS in developing countries; and new partnerships between the public sector and the pharmaceutical industry" 12/01/2003 - "Both women and men liked the dual role of contraception and protection against STIs including HIV/AIDS played by the female condom" 08/01/2002 - "The program includes an epidemiological surveillance modeling system, which records cases from several regular epidemiological bulletins; national network of diagnosis and monitoring of HIV-infected individuals (ill or not); highly active antiretroviral therapy available free to all patients; mother-infant protection program; educational programs on condom use; the introduction of the female condom; development of AIDS studies in different areas to provide practical solutions; constant preoccupation about drug costs accounting for the patent breaking; and national production of many drugs currently in use" 07/01/2001 - "Consumer preference study of the female condom in a sexually active population at risk of contracting AIDS." 04/01/2000 - "The present study used the theory of planned behavior (TPB) (Ajzen, 1985) augmented by AIDS knowledge to investigate factors influencing intentions of Hispanic adults to use the female condom" Order ALL the reference details at left...
3.	HIV Infections (HIV Infection) 08/01/1998 - "The male condom in particular (and probably the female condom) has the special value of providing protection against HIV infection" 11/01/1999 - "OBJECTIVES: This study assessed use of Reality "female condoms" for anal sex by HIV-seronegative men who have sex with men and are at high risk for HIV infection" 05/01/1998 - "A study conducted in Lusaka, Zambia, sought to determine whether couples at high risk of HIV infection would use the female condom over a 1-year period and if such use would lead to a reduction in unprotected coital acts" 01/01/2007 - "CONCLUSION: Postabortion care programs provide an excellent entry point for introducing the female condom as a contraceptive method for the prevention of both repeat unwanted pregnancies and STI/HIV infection." 10/24/2006 - "DESIGN: Cost-effectiveness analysis assessing HIV infections averted annually and incremental cost per HIV infection averted for country-wide distribution of the nitrile female condom (FC2) among sexually active individuals, 15-49 years, with access to publicly distributed condoms in Brazil and South Africa" Order ALL the reference details at left...
4.	Infection 01/01/2003 - "The female condom provides an important alternative means of protection against HIV and other sexually transmitted infections for women, particularly in situations where partners are reluctant or refuse to use male condoms" 08/01/2007 - "METHODS: SWs from two study clinics in Madagascar participated in a randomized trial to assess the effect of peer education and clinic-based counseling on use of male and female condoms and prevalence of sexually transmitted infections (STIs)" 01/01/2007 - "BACKGROUND: This study describes the outcome of a postabortion care intervention aimed at introducing the female condom as a means of preventing women from having unwanted pregnancies and sexually transmitted infections (STIs)/HIV" 10/01/2006 - "These five studies indicated strongly the benefits of female-condom use in increasing protected sex acts, and two studies found promising decreases in sexually transmitted infection (STI) incidence with the introduction of the female condom" 07/01/2001 - "We conducted a cluster-randomized community intervention trial at Kenyan agricultural sites to measure the impact of female condom introduction on sexually transmitted infection (STI) prevalence" Order ALL the reference details at left...
5.	Hypesthesia (Numbness) 02/01/1996 - "Enhanced enjoyment of sex, protection against pregnancy and sexually transmitted diseases, and female control were the most frequently cited positive attributes of the female condom; the device's large size, messiness, and reduced sensation were its least liked characteristics" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Polyurethanes (Polyurethane)
2.	Latex
3.	Nonoxynol (Nonoxynol 9)
4.	siliconized nylon
5.	Medroxyprogesterone 17-Acetate (Depo-Provera)
6.	Levonorgestrel (Plan B)
7.	Contraceptive Agents (Contraceptives)
8.	Anti-Infective Agents (Microbicides)
9.	Vaccines
10.	Copper

Related Therapies and Procedures

1.	Condoms (Condom)
2.	Female Condoms (Female Condom)
3.	Contraception (Birth Control)
4.	Highly Active Antiretroviral Therapy (HAART)
5.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Sexually Transmitted Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 239 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>